UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Nov

    30

    World's Leading Life Science Companies Now Enrolling COMMUNITY, a Global, Platform Trial for Hospitalized Patients with COVID-19

    Nov

    23

    New Digital Treatment Tracker for People Living with Epilepsy

    During Epilepsy Awareness Month, as part of our commitment to providing solutions that positively impact the lives of patients with neurological conditions, we enthusiastically announce a new initiative with Medisafe – the leading integrated medication management platform, personalized to engage patients and deliver outcomes.  

    Nov

    20

    Even with Tragedy, There is Hope: The Powerful Love of a Caregiver

    This National Family Caregivers Month, we honor and thank the many caregivers that selflessly care for their loved ones each day. Kristi Lengyel, UCB’s Head of Healthcare System Strategy, knows firsthand the burden many caregivers feel when a loved one experiences a life or death situation. Read her story. 

    Nov

    18

    UCB Unleashes the Power of Data in New Collaboration

    UCB and Stanford Medicine have established a multi-year collaboration to enhance patient value for people living with severe diseases.

    Nov

    17

    Michele’s Story: Living with Tonic-Clonic Seizures

    Michele has lived with tonic-clonic seizures since the age of 28 when she experienced her first seizure while swimming in a pool. This Epilepsy Awareness Month, read about her journey to seizure freedom. 

    Nov

    17

    UCB’s VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy

    Nov

    12

    UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms

    Nov

    11

    Hiring Our Heroes: UCB’s Commitment to Veterans in the Workplace

    This Veterans Day, UCB is proud to highlight three of our veterans as they share their transition from the military to the civilian workforce, and what it means to be a veteran at UCB.

    Nov

    05

    UCB Showcases Key Rheumatology Data at American College of Rheumatology Convergence 2020

    Nov

    04

    Recognizing Non-Radiographic Axial Spondyloarthritis Patients

    As we join the rheumatology community at ACR Convergence 2020, Head of U.S. Medical Immunology, Dr. Jeff Stark, shares the importance of a new diagnostic code for nr-axSpA in helping to improve the patient journey and to lead to more innovation. Read more.